Biora Therapeutics undertakes Chapter 11 sale process to position business for future growth.

Learn more
Biora Therapeutics Home
Activate the mobile navigation

Publications

Evaluation of the pharmacokinetics of PGN-OB1 following oral administration of an oral biotherapeutics delivery system (OBDS) in Yucatan swine
#BioJet Oral Therapeutic Delivery
Development of ex-vivo and in-vivo models to assess the performance of an oral biotherapeutic delivery system (OBDS) capsule
#BioJet Oral Therapeutic Delivery
Development of preclinical models to assess the performance of the oral biotherapeutic delivery system (OBDS) capsule
#BioJet Oral Therapeutic Delivery
A novel method for collecting microbiome specimens: proof of concept in normal healthy volunteers
#SIBO & Microbiome
Pharmacokinetic stratification of cytokine profiles during anti-TNF induction treatment in moderate-to-severe ulcerative colitis
#NaviCap Targeted Therapeutic Delivery
Tofacitinib tissue exposure correlates with endoscopic outcome
#NaviCap Targeted Therapeutic Delivery
Development of a novel drug delivery system to deliver drugs directly to the colonic mucosa
#NaviCap Targeted Therapeutic Delivery
Development of a novel drug delivery system for targeted treatment of ulcerative colitis
#NaviCap Targeted Therapeutic Delivery
Targeted delivery of tofacitinib citrate to the site of disease to improve efficacy and safety
#NaviCap Targeted Therapeutic Delivery